You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses

Citation Tools

Article menu

Download PDFPDF

Research Article
Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Dillman RO, Cornforth AN, Nistor GI, et al
Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses
Journal for ImmunoTherapy of Cancer 2018;6:19. doi: 10.1186/s40425-018-0330-1